Risk factor
Weak & very vulnerable to price shocks
Profitability factor
Favourable analyst view
About
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero...
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is 'expensive' on EV/EBITDA.
Target Price
The average target price of ANGO is 20 and suggests 53% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell